Paul B. Rothman, MD. CEO of Johns Hopkins Medicine (Baltimore). Dr. Rothman — a rheumatologist and molecular immunologist — is the CEO of Johns Hopkins Medicine, the vice president for medicine of The Johns Hopkins University and the Frances Watt Baker, M.D., and Lenox D. Baker Jr., M.D., Dean of the Medical Faculty. The health system Dr. Rothman oversees encompasses six hospitals, hundreds of community physicians and a self-funded health plan. In 2015, Dr. Rothman signed a memorandum of understanding to partner Johns Hopkins Medicine with Chinese company DIAN Diagnostics to spread DIAN’s pathology lab services nationwide. He was also appointed to the board of the Center for Medical Interoperability, a nonprofit organization focused on accelerating the seamless exchange of health information.
 |
 |
 |
| Return to Full List | + |
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
